Cell X Technologies - About the company
Cell X Technologies is a funded company based in Cleveland (United States), founded in 2017 by George Muschler, Kimberly Powell and Peter Johnson. It operates as a Developer of regenerative medicine to measure and manage human cell sources. Cell X Technologies has raised an undisclosed amount in funding. The company has 160 active competitors, including 54 funded and 23 that have exited. Its top competitors include companies like 10X Genomics, Oribiotech and Pandorum.
Company Details
Cell X Technologies is a developer of regenerative medicine to measure and manage human cell sources. It has developed medicines by using integrated strategies of imaging, analytics, and automation to measure human cells. It has developed a Cell X device that helps users to view the imaging of cell populations in culture. It uses quantitative image analysis of cells and colonies using ASTM standards via ColonyzeTM software. The Cell X platform is designed to be used in a GMP quality environmental control system. It can be paired with a plate mover robot & can be scheduled to manage protocol workflow.
- Website
- cellxtechnologies.com
- Email ID
- *****@cellxtechnologies.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2017
Location
Cleveland, United States
Stage
Funding Raised
Latest Funding Round
Investors
Ranked
57th among 160 active competitors
Employee Count
14 as on Jun 30, 2026
Similar Companies
Sign up to download Cell X Technologies' company profile
Cell X Technologies's funding and investors
Cell X Technologies has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Sep 12, 2019 for $*****. 1 investor participated in its latest round. Cell X Technologies has 4 institutional investors.
Here is the list of recent funding rounds of Cell X Technologies:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 12, 2019 | 6833771 | Grant (prize money) | 4233716 | 6273477 | 6530411 | 4361158 |
View details of Cell X Technologies's funding rounds and investors
Cell X Technologies' founders and board of directors
Founder? Claim ProfileHere are the details of Cell X Technologies' key team members:
- George Muschler: Founder & CSO of Cell X Technologies. Contact Info: 1 email address
- Kimberly Powell: Founder of Cell X Technologies.
- Peter Johnson: Founder of Cell X Technologies. Contact Info: 1 email address
View details of Cell X Technologies's Founder profiles and Board Members
Cell X Technologies' employee count trend
Cell X Technologies has 14 employees as of Jun 26. Here is Cell X Technologies's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cell X Technologies's Competitors and alternates
Top competitors of Cell X Technologies include 10X Genomics, Oribiotech and Pandorum. Here is the list of Top 10 competitors of Cell X Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | 10X Genomics 2012, Pleasanton (United States), Public | Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis | $243M | 77/100 | |
2nd | Oribiotech 2015, London (United Kingdom), Series B | Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool | $281M | 66/100 | |
3rd | Developer of regenerative medicine and 3D tissues | $52.1M | 65/100 | ||
4th | Mission Bio 2014, San Francisco (United States), Series C | Provider of single cell multiomics platform for genotypic and phenotypic analysis | $120M | 65/100 | |
5th | Cellares 2019, San Francisco (United States), Series D | Manufacturer of a medical device for cell-based therapy | $682M | 64/100 | |
6th | Multiply Labs 2016, San Francisco (United States), Series A | Manufacturer of precision medicines through innovative robotic technology | $41.3M | 64/100 | |
7th | Atrandi Biosciences 2016, Vilnius (Lithuania), Series A | A life sciences tool company transforming single-cell research with its patented Semi-Permeable Capsule(SPC) technology, enabling high-throughput and multi-step workflows | $31M | 64/100 | |
8th | LUMICKS 2014, Amsterdam (Netherlands), Series D | Manufacturer of optical tweezers for single molecule analysis instruments | $93.4M | 63/100 | |
9th | One Biosciences 2020, Paris (France), Series A | Developer of single-cell therapeutics solutions to treat multiple health disorders | $22.4M | 62/100 | |
10th | Xcell Biosciences 2012, San Francisco (United States), Series B | Developer of cell culture analysis device for cancer research | $40.9M | 59/100 | |
57th | Cell X Technologies 2017, Cleveland (United States), Funding Raised | Developer of regenerative medicine to measure and manage human cell sources | - | 35/100 |
Looking for more details on Cell X Technologies's competitors? Click here to see the top ones
Cell X Technologies's Investments and acquisitions
Cell X Technologies has made no investments or acquisitions yet.
Reports related to Cell X Technologies
Here is the latest report on Cell X Technologies's geography:
News related to Cell X Technologies
Media has covered Cell X Technologies for 1 event in last 1 year, It was about partnerships.
•
Are you a Founder ?
FAQs about Cell X Technologies
Explore our recently published companies
- Dashcam center - Nairobi based, 2016 founded, Unfunded company
- EasyPOS BD - Dhaka based, Unfunded company
- Stratinis - London based, 2006 founded, Unfunded company
- AIP Electronics - Bakersfield based, 2005 founded, Unfunded company
- OceanX - El Segundo based, Acquired company
- Rent in Hand - Rostov-on-Don based, 2009 founded, Unfunded company